StonvexLoading…
StonvexStonvexStonvexCore line items from MYSZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.36M | $8.26M | $7.00M | $4.46M |
Operating Income | $-5.74M | $-3.94M | $-6.74M | $-8.11M |
Net Income | $-5.85M | $-4.00M | $-6.38M | $-8.31M |
EPS (Diluted) | $-1.87 | $-4.39 | $-20.40 | $-7.47 |
Total Assets | $10.20M | $10.06M | $8.99M | $9.73M |
Total Liabilities | $5.05M | $3.15M | $4.26M | $5.19M |
Cash & Equivalents | $2.30M | $4.88M | $2.19M | $2.10M |
Free Cash Flow OCF − CapEx | $-5.16M | $-3.10M | $-6.11M | $-7.32M |
Shares Outstanding | 4.64M | 2.04M | 452.72K | 1.46M |